Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-012-2018-4
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2012
Authors
Publisher
Springer Science and Business Media LLC